Lorenzo Galluzzi chercheur italien
Galluzzi, Lorenzo.
Galluzzi, Lorenzo, 1980-....
VIAF ID: 297157448 (Personal)
Permalink: http://viaf.org/viaf/297157448
Preferred Forms
-
-
- 100 1 _ ‡a Galluzzi, Lorenzo
- 100 1 _ ‡a Galluzzi, Lorenzo
-
- 100 1 _ ‡a Galluzzi, Lorenzo
-
-
- 100 1 _ ‡a Galluzzi, Lorenzo ‡d 1980-
- 100 1 _ ‡a Galluzzi, Lorenzo, ‡d 1980-....
-
- 100 0 _ ‡a Lorenzo Galluzzi ‡c chercheur italien
4xx's: Alternate Name Forms (10)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Actin cytoskeleton in cancer progression and metastasis. | |
Biology of the endoplasmic reticulum | |
CAR T cells : development, characterization and applications | |
Carcinogen-driven mouse models of oncogenesis | |
Cell death regulation in health and disease. | |
Cell senescence, [2013]: | |
Cell-wide metabolic alterations associated with malignancy | |
Cellular and molecular aspects of myeloproliferative neoplasms. | |
Cellular immunity in the peritoneum | |
Cilia : from mechanisms to disease. | |
Conceptual background and bioenergetic/mitochondrial aspects of oncometabolism | |
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 | |
Extracellular vesicles | |
Immunobiology of dendritic cells. | |
The immunological synapse. | |
Immunopathology of celiac disease | |
In situ abscopal effect : spatiotemporal modulation of the tumor immune micro- environment after partial stereotactic irradiation | |
Inter-organellar Ca2+ signaling in health and disease. | |
International review of cell and molecular biology. | |
Methods in stem cell biology. | |
Mitochondria and longevity | |
Molecular characterization of autophagic responses. | |
Molecular mechanisms of cell death : recommendations of the Nomenclature Committee on Cell Death 2018 | |
Monitoring vesicular trafficking in cellular responses to stress. | |
mRNA-based therapeutics | |
New antibody formats | |
Nucleic acid sensing and immunity. | |
Nutrition and cancer | |
One, no one, one hundred thousand : the multifaceted role of macrophages in health and disease. | |
Peptide mimics of the thrombospondin C-terminal binding domain : analysis of their therapeutic potential to trigger immunogenic death of cancer cells targeting the TSP1–CD47 axis | |
Radiation oncology and radiotherapy. | |
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing. | |
Secondary Necrosis: Accidental No More | |
The secret ally: immunostimulation by anticancer drugs | |
Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-review | |
Shigella targets the mitochondrial checkpoint of programmed necrosis | |
Signal transduction in cancer and immunity | |
STAT3 inhibition for cancer therapy: Cell-autonomous effects only? | |
Stress responses in stromal cells and tumor homeostasis | |
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. | |
Surface-exposed calreticulin in the interaction between dying cells and phagocytes | |
Systems biology of cisplatin resistance: past, present and future | |
Tabibi Sabbu | |
Targeting p53 to mitochondria for cancer therapy | |
Today's Special on the Anticancer Menu: Immunomodulation by Antifolates | |
TP53 and MTOR crosstalk to regulate cellular senescence | |
Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? | |
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing | |
TREX1 Cuts Down on Cancer Immunogenicity | |
Trial Watch: Adoptively transferred cells for anticancer immunotherapy. | |
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology | |
Trial watch: dietary interventions for cancer therapy | |
Trial Watch: Immunostimulatory cytokines | |
Trial watch: Naked and vectored DNA-based anticancer vaccines | |
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors | |
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer | |
Trial Watch: Toll-like receptor agonists in cancer immunotherapy | |
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications | |
"TripleC" : une étude de biologie des systèmes sur l'apoptose | |
Tumor immunology and immunotherapy : integrated methods. | |
Unsaturated fatty acids induce non-canonical autophagy | |
Victories and deceptions in tumor immunology: Stimuvax(®) | |
Viperin turns coat in cytomegalovirus infection | |
Viral control of mitochondrial apoptosis | |
Viral subversion of immunogenic cell death | |
Whole cell strategies based on lux genes for high throughput applications toward new antimicrobials |